A large, multi-national therapeutic and diagnostic technology company with more than 12,000 medical and scientific patents and more than 80 industry awards for excellence needed help to conduct a burden of illness study for anastomotic leaks on bariatric and colorectal procedures.
The client needed to generate evidence demonstrating the increased length of stay, costs and readmission rates associated with anastomotic leaks. Additionally, the client wanted to develop industry-facing communication exhibiting the economic value of its product.
Baker Tilly generated real-world evidence confirming the impact anastomotic leaks have on the healthcare industry and analyzed payer-focused, real-world data to assess the economic and clinical outcomes. With this information, Baker Tilly developed a publication strategy that targeted key audiences of high-impact journals. Within this strategy, a scientific manuscript was developed that outlined the favorable cost-savings outcomes associated with utilization of the product.
Through the insights generated from Baker Tilly’s analyses, the client was able to strengthen its cost effectiveness position with payers and providers. A high-impact, peer-reviewed journal accepted and published the manuscript outlining the cost savings of the client's product in comparison to standard of care. Baker Tilly hosted a webinar on behalf of the client to potential providers that could leverage the client’s products based on the outcomes of the burden of illness study for anastomotic leaks.